MCP Prompts

DAILY STANDUP BRIEFING — Brussels Filling Line
═══════════════════════════════════════════════

KPI ALERTS: 2 active
━━━━━━━━━━━━━━━━━━━
1. OEE — 82.5% (AMBER) | Target: 90% | Green: ≥85%
   Root cause: Line 2 seal failure, 45min unplanned downtime
   → Maintenance scheduled for tonight's shift

2. Right First Time — 96.2% (AMBER) | Target: 99% | Green: ≥98%
   Root cause: 3 labeling rejects on secondary packaging
   → Not a product quality issue; label printer alignment checked

OVERDUE ACTIONS: 3
━━━━━━━━━━━━━━━━━
1. [CRITICAL] CAPA-2026-0187: Replace conveyor belt section 3
   Owner: Dr. Chen | Due: Apr 5 (8 days overdue) | Tier 1
   → Parts arrived yesterday. Scheduled for installation tonight.

2. [HIGH] Review SOP-MFG-042 temperature monitoring procedure
   Owner: J. Dubois | Due: Apr 10 (3 days overdue) | Tier 1
   → Draft complete, pending QA review.

3. [MEDIUM] Update training records for new filling operators
   Owner: S. Van Damme | Due: Apr 11 (2 days overdue) | Tier 1
   → 3 of 5 operators completed. Remaining 2 scheduled this week.

TODAY'S PRIORITIES:
1. Complete CAPA-0187 conveyor belt installation (safety critical)
2. Get QA sign-off on SOP-MFG-042 revision
3. Monitor OEE recovery after seal replacement
4. Close labeling issue on secondary packaging line

BOARD HEALTH ANALYSIS — CAPA Tracking
══════════════════════════════════════

BOTTLENECK: "In Review" group has 14 items (47% of total)
  Average time in "In Review": 8.3 days
  → Recommendation: Add a WIP limit of 5. Assign a dedicated QA reviewer
    for weekly CAPA review sessions.

WORKLOAD IMBALANCE:
  Dr. Chen: 9 items (30%)  ← Overloaded
  J. Dubois: 6 items (20%)
  S. Van Damme: 3 items (10%)
  Unassigned: 12 items (40%) ← High unassigned rate
  → Recommendation: Redistribute 3 items from Dr. Chen. Assign the
    12 unassigned items during the next tier meeting.

COLUMN USAGE:
  "Due Date" populated: 73% (8 items missing due dates)
  "Priority" populated: 100%
  "Root Cause Category" populated: 45% ← Low
  → Recommendation: Make "Root Cause Category" required. Missing
    categorization prevents trend analysis.

TIER ESCALATION REPORT — Brussels Manufacturing Site
═════════════════════════════════════════════════════

EXECUTIVE SUMMARY:
23 total actions across 3 tiers. 2 critical escalations require
immediate site director attention.

TIER 3 — SITE (2 actions)
━━━━━━━━━━━━━━━━━━━━━━━━
[CRITICAL] Capital request: Replace aging filling line isolator
  Escalated from T2 on Apr 8. Estimated cost: EUR 450K.
  Impact: Current isolator has 3 integrity failures in 6 months.
  Recommendation: Fast-track capital approval. Patient safety risk.

[HIGH] Cross-department API supply chain contingency
  Escalated from T2 on Apr 5. Single-source API from India.
  Recommendation: Qualify backup supplier. 9-month lead time.

TIER 2 — DEPARTMENT (7 actions)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
  Quality: 4 actions (3 overdue)
  Delivery: 2 actions
  Safety: 1 action
  → PATTERN: Quality actions dominate T2. Root cause: insufficient
    QA reviewer capacity. Recommend hiring additional QC analyst.

TIER 1 — TEAM (14 actions)
━━━━━━━━━━━━━━━━━━━━━━━━━━
  Open: 3 | Assigned: 5 | In Progress: 4 | Blocked: 2
  → 2 blocked actions need T2 escalation (waiting on parts procurement)

WEEKLY SQCDP KPI REVIEW — Brussels Filling Line
════════════════════════════════════════════════
Week of April 7-13, 2026

SAFETY [GREEN] ✓
  LTI Rate: 0 (target: 0) — 847 days without LTI
  Near-misses: 2 reported (target: >5 reports/week)
  → Trend: Stable. Near-miss reporting below target — may indicate
    under-reporting rather than good performance. Recommend safety
    observation blitz this week.

QUALITY [AMBER] ⚠
  Right First Time: 96.2% (target: 99%, threshold: 98%)
  Batch Rejection Rate: 0.8% (target: <0.5%)
  → Trend: Degrading. 3rd consecutive week below target.
  → Root cause: Labeling accuracy on secondary packaging.
  → Corrective action: Replace label printer on Line 2 (ordered).
  → GxP impact: No product quality impact. Cosmetic defect only.

COST [GREEN] ✓
  Cost per unit: EUR 2.34 (target: EUR 2.50)
  Scrap rate: 0.3% (target: <1%)

DELIVERY [AMBER] ⚠
  OEE: 82.5% (target: 90%, threshold: 85%)
  OTIF: 94% (target: 98%)
  → Trend: Improving (was 79.1% last week).
  → Root cause: Unplanned downtime on Line 2 (seal failure).
  → Corrective action: CAPA-0187 in progress. Seal replaced.
  → GxP impact: 2 batch deliveries delayed by 24 hours.

PEOPLE [GREEN] ✓
  Absenteeism: 3.2% (target: <5%)
  Training completion: 87% (target: 95%)
  → Training gap: 5 operators pending GMP refresher course.

OVERALL HEALTH SCORE: 7/10
TOP 3 PRIORITIES:
1. Close quality gap — label printer replacement (due Apr 15)
2. Sustain OEE recovery — monitor Line 2 after seal replacement
3. Complete operator GMP training (5 remaining)

CAPA ANALYSIS REPORT — Brussels Filling Line
═════════════════════════════════════════════
Generated: 2026-04-13 | For QMS record insertion

CAPA-2026-0194: Batch BX-4471 OOS — pH Excursion
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

ISSUE DESCRIPTION:
  What: pH reading 7.8 on Batch BX-4471 (spec: 7.0-7.4)
  When: 2026-04-06 during in-process testing
  Severity: Major — batch held pending investigation
  Impact: 1 batch affected, no patient exposure (batch not released)

ROOT CAUSE ANALYSIS (5 Whys):
  Why 1: Buffer pH was out of range
  Why 2: NaOH concentration in buffer preparation was incorrect
  Why 3: Operator used reagent-grade NaOH instead of USP-grade
  Why 4: Both grades stored in same cabinet with similar labels
  Why 5: SOP-WH-012 does not address reagent grade segregation
  ROOT CAUSE: Inadequate warehouse SOP for reagent grade segregation

CORRECTIVE ACTION:
  Action: Segregate NaOH grades into separate, labeled cabinets
  Responsible: J. Dubois (Warehouse Manager)
  Deadline: 2026-04-15
  Status: In progress — cabinets ordered, arriving Apr 14

PREVENTIVE ACTION:
  Action: Update SOP-WH-012 to require grade-specific storage locations
         with color-coded labels and barcode verification at dispensing
  Responsible: Dr. Chen (QA Manager)
  Deadline: 2026-04-25
  Training: All warehouse staff to be retrained on updated SOP

EFFECTIVENESS CHECK:
  Method: 30-day monitoring of buffer preparation records
  Metric: Zero reagent grade errors over 30 consecutive days
  Review date: 2026-05-25
  Reviewer: QA Director

GxP IMPACT ASSESSMENT:
  Product quality: No released product affected (batch held)
  Patient safety: No risk (batch not distributed)
  Data integrity: All records maintained; no ALCOA concern
  Regulatory: Potential FDA 483 observation if systemic issue identified
              Recommend voluntary disclosure in next annual report

{
  "method": "prompts/list",
  "params": {}
}

// Response
{
  "prompts": [
    { "name": "daily_standup", "description": "Daily Standup Summary" },
    { "name": "board_analysis", "description": "Board Health Analysis" },
    { "name": "escalation_report", "description": "Tier Escalation Report" },
    { "name": "kpi_review", "description": "Weekly KPI Review (SQCDP)" },
    { "name": "capa_analysis", "description": "CAPA Analysis (Corrective & Preventive Action)" }
  ]
}

User: Analyze our site's readiness for the upcoming FDA audit.

Claude: I'll gather the data from multiple sources.
  [list_compliance_requirements] → 47 requirements, 3 with gaps
  [list_inspection_checklists] → 5 checklists, 1 overdue session
  [list_actions with category=quality and overdue=true] → 6 overdue CAPAs
  [get_kpi_alerts] → 2 KPIs in amber state

Based on the data, here is your FDA audit readiness assessment:
  ...